- Home
- YJ vs VYNE Comparison
YJ vs VYNE Comparison
Compare YJ & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- VYNE
- Stock Information
- Founded
- YJ 2015
- VYNE 2003
- Country
- YJ China
- VYNE United States
- Employees
- YJ N/A
- VYNE N/A
- Industry
- YJ Other Specialty Stores
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- YJ Consumer Discretionary
- VYNE Health Care
- Exchange
- YJ Nasdaq
- VYNE Nasdaq
- Market Cap
- YJ 9.3M
- VYNE 7.9M
- IPO Year
- YJ 2019
- VYNE 2018
- Fundamental
- Price
- YJ N/A
- VYNE $0.43
- Analyst Decision
- YJ
- VYNE Buy
- Analyst Count
- YJ 0
- VYNE 2
- Target Price
- YJ N/A
- VYNE $8.00
- AVG Volume (30 Days)
- YJ 21.8K
- VYNE 3.1M
- Earning Date
- YJ 11-20-2025
- VYNE 11-06-2025
- Dividend Yield
- YJ N/A
- VYNE N/A
- EPS Growth
- YJ N/A
- VYNE N/A
- EPS
- YJ N/A
- VYNE N/A
- Revenue
- YJ $47,760,127.00
- VYNE $476,000.00
- Revenue This Year
- YJ N/A
- VYNE N/A
- Revenue Next Year
- YJ N/A
- VYNE N/A
- P/E Ratio
- YJ N/A
- VYNE N/A
- Revenue Growth
- YJ N/A
- VYNE N/A
- 52 Week Low
- YJ $1.37
- VYNE $0.28
- 52 Week High
- YJ $2.67
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- YJ 68.81
- VYNE 60.37
- Support Level
- YJ $1.93
- VYNE $0.32
- Resistance Level
- YJ $2.67
- VYNE $0.35
- Average True Range (ATR)
- YJ 0.13
- VYNE 0.02
- MACD
- YJ 0.02
- VYNE 0.02
- Stochastic Oscillator
- YJ 44.18
- VYNE 84.88
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.